Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Martin B Leon, MD
Columbia University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cardiology, Pc
Birmingham, Alabama, United States
- Cedars - Sinai Medical Center
Los Angeles, California, United States
- Mount Sinai Medical Center
Miami Beach, Florida, United States
- Cardiovascular Institute of the South
Houma, Louisiana, United States
- University of Maryland
Baltimore, Maryland, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Columbia University Medical Center
New York, New York, United States
- Albert Einstein Medical Center
Philadelphia, Pennsylvania, United States
- Wellmont Cva Heart Institute
Kingsport, Tennessee, United States
- Cardiovascular Research Institute of Dallas
Dallas, Texas, United States
- Dallas Medical Center
Dallas, Texas, United States
- Aspirus Heart and Vascular Institute
Wausau, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2015
- Primary completion
- 7 Sept 2017
- Completion
- 2 Aug 2019
- Last update posted
- 11 Feb 2021
- Registered enrollment
- 51
- Registry id
- NCT02392351
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.